Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

Digestive Diseases

Volumn 34, Issue 3, 2016, Pages 202-209

  Lopetuso, L R ^a   Petito, V ^a   Zambrano, D ^a   Orlando, D ^a   Dal Lago, A ^a   Serrichhio, L ^a   Papa, A ^a   Gasbarrini, A ^a   Scaldaferri, F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Gut microbiota; Inflammatory bowel disease; Mucosal healing; Mucosal injury

Indexed keywords

BUTYRIC ACID; MATRIX METALLOPROTEINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

EPITHELIUM; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE INJURY; MUCOSAL DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; WOUND HEALING; BACTERIUM; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

BACTERIA; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; WOUND HEALING;

EID: 84971633768     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000444460     Document Type: Review

References (69)

1. Bamias G, et al: New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 2012; 59: 451-459.
2. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434.
3. Jostins L, et al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
4. Khor B, Gardet A, Xavier RJ: Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-317.
5. de Bruyn M, et al: Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 339-352.
6. Scaldaferri F, et al: The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol 2012; 46(suppl):S12-S17.
7. Scaldaferri F, et al: Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility. Biomed Res Int 2013; 2013: 435268.
8. Rogler G, et al: Mucosal healing and deep remission: what does it mean? World J Gastroenterol 2013; 19: 7552-7560.
9. Macdonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science 2005; 307: 1920-1925.
10. Neurath MF: New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol 2014; 7: 6-19.
11. Rieder F, et al: Results of the 2nd scientific workshop of the ECCO (III): Basic mechanisms of intestinal healing. J Crohns Colitis 2012; 6: 373-385.
12. Maxwell PH, et al: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275.
13. Semenza GL: Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 1998; 8: 588-594.
14. Giatromanolaki A, et al: Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol 2003; 56: 209-213.
15. Stappenbeck TS, Hooper LV, Gordon JI: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002; 99: 15451-15455.
16. Zocco MA, et al: Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis 2007; 39: 707-712.
17. Schirbel A, et al: Pro-angiogenic activity of TLRs and NLRs: A novel link between gut microbiota and intestinal angiogenesis. Gastroenterology 2013; 144: 613-623. e9.
18. McKenzie SJ, et al: Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996; 98: 136-141.
19. Kruidenier L, et al: Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J Pathol 2003; 201: 7-16.
20. Sokol H, et al: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105: 16731-16736.
21. Sokol H, et al: Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15: 1183-1189.
22. Darfeuille-Michaud A, et al: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421.
23. Baumgart M, et al: Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007; 1: 403-418.
24. Kotlowski R, et al: High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007; 56: 669-675.
25. Lupp C, et al: Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204.
26. Naser SA, et al: Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004; 364: 1039-1044.
27. Rigottier-Gois L: Dysbiosis in inflammatory bowel diseases: The oxygen hypothesis. ISME J 2013; 7: 1256-1261.
28. Hooper LV, et al: Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays 1998; 20: 336-343.
29. Kumar A, et al: Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J 2007; 26: 4457-4466.
30. Kumar A, et al: The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J Immunol 2009; 182: 538-546.
31. Cerignoli F, et al: Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation. Cell Cycle 2006; 5: 2210-2215.
32. Wentworth CC, et al: Enteric commensal bacteria induce extracellular signal-regulated kinase pathway signaling via formyl peptide receptor-dependent redox modulation of dual specific phosphatase 3. J Biol Chem 2011; 286: 38448-38455.
33. Baugh MD, et al: Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999; 117: 814-822.
34. Laukoetter MG, Nava P, Nusrat A: Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2008; 14: 401-407.
35. McGuckin MA, et al: Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15: 100-113.
36. Viswanathan VK, et al: Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun 2004; 72: 3218-3227.
37. Amieva MR, et al: Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-1434.
38. Babbin BA, et al: The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases. Am J Pathol 2009; 174: 1347-1357.
39. Li Q, et al: Invasion of enteropathogenic Escherichia coli into host cells through epithelial tight junctions. FEBS J 2008; 275: 6022-6032.
40. Jepson MA, Schlecht HB, Collares-Buzato CB: Localization of dysfunctional tight junctions in Salmonella enterica serovar typhimurium-infected epithelial layers. Infect Immun 2000; 68: 7202-7208.
41. Sakaguchi T, et al: Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell Microbiol 2002; 4: 367-381.
42. Chen ML, et al: Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infect Immun 2006; 74: 6581-6589.
43. Phan QT, et al: Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 2007; 5:e64.
44. Moreno-Ruiz E, et al: Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell Microbiol 2009; 11: 1179-1189.
45. Wu S, et al: Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J Cell Sci 2007; 120(pt 11):1944-1952.
46. Steck N, et al: Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 2011; 141: 959-971.
47. Comito D, Cascio A, Romano C: Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr 2014; 40: 32.
48. Zhan Y, et al: Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res 2013; 73: 7199-7210.
49. Pull SL, et al: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A 2005; 102: 99-104.
50. Rakoff-Nahoum S, et al: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
51. Swanson PA 2nd, et al: Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc Natl Acad Sci U S A 2011; 108: 8803-8808.
52. Guilloteau P, et al: From the gut to the peripheral tissues: The multiple effects of butyrate. Nutr Res Rev 2010; 23: 366-384.
53. Lewis K, et al: Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 2010; 16: 1138-1148.
54. Ukena SN, et al: Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007; 2:e1308.
55. Wang H, et al: Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage. Cancer Biol Ther 2014; 15: 560-569.
56. Donato KA, et al: Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 2010; 156(pt 11):3288-3297.
57. Patel RM, et al: Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 2012; 180: 626-635.
58. Orlando A, et al: Lactobacillus GG restoration of the gliadin-induced epithelial barrier disruption: The role of cellular polyamines. BMC Microbiol 2014; 14: 19.
59. Yan F, et al: Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132: 562-575.
60. Wang L, et al: Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J Biol Chem 2014; 289: 20234-20244.
61. Carlsson AH, et al: Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol 2013; 48: 1136-1144.
62. Wrzosek L, et al: Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 2013; 11: 61.
63. Dai C, Zhao DH, Jiang M: VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. Int J Mol Med 2012; 29: 202-208.
64. Czerucka D, et al: Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coliinfected T84 cells. Infect Immun 2000; 68: 5998-6004.
65. Thomas S, et al: Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2011; 301:G1083-G1092.
66. Percival SL, Thomas JG, Williams DW: Biofilms and bacterial imbalances in chronic wounds: Anti-Koch. Int Wound J 2010; 7: 169-175
67. Goldsmith JR, Sartor RB: The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014; 49: 785-798.
68. Garg SK, Croft AM, Bager P: Helminth therapy (worms) for induction of remission in inflammatory bowel disease. Cochrane Database Syst Rev 2014; 1:CD009400.
69. Hamady ZZ, et al: Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 2010; 59: 461-469.